EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines

Suman Karmakar, Mousumi Das, Monalisa Ray, Soumyadip Mukherjee, Sanhita Ghosh, Kamalika Roy, Chiranjib Pal

Zoonoses · 2024 · 4 (1)

DOI: 10.15212/zoonoses-2024-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zoonoses, 2024. Verfasst von Suman Karmakar und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniases are transmitted by the protozoan parasite Leishmania through the bites of infected sandflies. Despite the availability of various medications, rising resistance and toxicity levels underscore the urgent need to explore and create a reliable, safe vaccine for human use. Creating live attenuated promastigotes by genetically modifying essential gene targets affects their virulence without influencing their immunogenic attribution, and has shown highly promising reproducibility. These vaccines provide protection against challenge with virulent wild-type parasites. Advances in CRISPR/Cas9 gene editing technology have shown promise in enabling marker-free gene modification. Herein, our aim is to shed light on genetically modified Leishmania with the potential to confer protection against wild-type Leishmania challenge in animal models. Because of several limitations, the success has not been achieved to date. Therefore, additional potential candidates with high effectiveness must be assessed as potential vaccines in the future.

Zitieren

APA

Karmakar, S., Das, M., Ray, M., Mukherjee, S., Ghosh, S., Roy, K., & Pal, C. (2024). Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines. Zoonoses, 4(1). https://doi.org/10.15212/zoonoses-2024-0010

Vancouver

Karmakar S, Das M, Ray M, Mukherjee S, Ghosh S, Roy K, et al. Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines. Zoonoses. 2024;4(1). doi:10.15212/zoonoses-2024-0010

BibTeX
@article{Karmakar2024,
  author = {Karmakar, Suman and Das, Mousumi and Ray, Monalisa and Mukherjee, Soumyadip and Ghosh, Sanhita and Roy, Kamalika and Pal, Chiranjib},
  title = {Prospects and Challenges of Genetically Modified Live-Attenuated Leishmania Vaccines},
  journal = {Zoonoses},
  year = {2024},
  volume = {4},
  number = {1},
  doi = {10.15212/zoonoses-2024-0010}
}
Kostenlos starten →